Masimo Corp (MASI)
124.11
+4.09
(+3.41%)
USD |
NASDAQ |
May 09, 16:00
124.10
-0.01
(-0.01%)
After-Hours: 20:00
Masimo Enterprise Value: 7.315B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 09, 2024 | 7.315B |
May 08, 2024 | 7.098B |
May 07, 2024 | 7.946B |
May 06, 2024 | 8.052B |
May 03, 2024 | 7.999B |
May 02, 2024 | 7.959B |
May 01, 2024 | 7.841B |
April 30, 2024 | 7.862B |
April 29, 2024 | 7.957B |
April 26, 2024 | 7.954B |
April 25, 2024 | 7.906B |
April 24, 2024 | 7.942B |
April 23, 2024 | 7.997B |
April 22, 2024 | 7.857B |
April 19, 2024 | 7.881B |
April 18, 2024 | 7.942B |
April 17, 2024 | 7.979B |
April 16, 2024 | 8.062B |
April 15, 2024 | 8.058B |
April 12, 2024 | 8.048B |
April 11, 2024 | 8.304B |
April 10, 2024 | 8.308B |
April 09, 2024 | 8.419B |
April 08, 2024 | 8.325B |
April 05, 2024 | 8.291B |
Date | Value |
---|---|
April 04, 2024 | 8.174B |
April 03, 2024 | 8.192B |
April 02, 2024 | 8.182B |
April 01, 2024 | 8.415B |
March 31, 2024 | 8.522B |
March 28, 2024 | 8.513B |
March 27, 2024 | 8.388B |
March 26, 2024 | 8.185B |
March 25, 2024 | 8.121B |
March 22, 2024 | 7.883B |
March 21, 2024 | 7.784B |
March 20, 2024 | 7.778B |
March 19, 2024 | 7.906B |
March 18, 2024 | 7.804B |
March 15, 2024 | 7.764B |
March 14, 2024 | 7.738B |
March 13, 2024 | 7.840B |
March 12, 2024 | 7.573B |
March 11, 2024 | 7.584B |
March 08, 2024 | 7.856B |
March 07, 2024 | 7.842B |
March 06, 2024 | 7.604B |
March 05, 2024 | 7.598B |
March 04, 2024 | 7.456B |
March 01, 2024 | 7.436B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.870B
Minimum
Oct 16 2023
16.10B
Maximum
Nov 19 2021
9.707B
Average
8.819B
Median
Enterprise Value Benchmarks
Integer Holdings Corp | 4.926B |
Stryker Corp | 136.50B |
Insulet Corp | 13.13B |
Shockwave Medical Inc | 12.12B |
PROCEPT BioRobotics Corp | 3.061B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 18.90M |
Revenue (Quarterly) | 492.80M |
Total Expenses (Quarterly) | 458.80M |
EPS Diluted (Quarterly) | 0.35 |
Gross Profit Margin (Quarterly) | 49.05% |
Profit Margin (Quarterly) | 3.84% |
Earnings Yield | 1.18% |
Operating Earnings Yield | 2.39% |
Normalized Earnings Yield | 1.510 |